Washington SB 5371: Protecting consumers and purchasers from excessive increases in insulin drug prices.

Status: By resolution, reintroduced and retained in present status. (as of 2020-01-13)

State: Washington · Session: 2019-2020 · Bill: SB 5371

Subjects: HEALTH AND SAFETY, PUBLIC, DRUGS

Sponsors: Keiser, Bailey, Cleveland, Conway, Darneille, Das, Frockt, Hasegawa, Kuderer, Mullet, Nguyen, Rivers, Rolfes, Saldaña, Van De Wege

View Washington SB 5371 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.